Judge Your Health

His and hers has emerged as a popular name in the USA. It has launched within the US as the cheapest GLP-1 weight reduction tablet, priced at round $49 for the primary month and $99 thereafter, undercutting Novo Nordisk's Wegovy tablet and surprising buyers.  The compound semaglutide product aims to extend access to obesity remedy. However it lacks FDA approval, and hence it receives threats from Novo and regulatory scrutiny from the FDA over safety and marketing claims. The